You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

locally Advanced Rectal Cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Paclitaxel plus 5-fluorouracil, Cisplatin plus 5-fluorouracil, Radiation

Completed
  • Esophageal Squamous Cell Carcinoma
  • Paclitaxel plus 5-fluorouracil
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Cancer Center
Oct 17, 2018

Lung Cancer, Video-assisted Thoracic Surgery, EGFR Trial in Torino (Cetuximab-IRDye800)

Not yet recruiting
  • Lung Cancer
  • +3 more
  • Torino, TO, Italy
    Azienda Ospedaliera Universitaria Città della Salute e della Sci
Oct 23, 2023

Musculoskeletal Syndrome Trial in Minneapolis (CBD-dominant, THC dominant)

Recruiting
  • Musculoskeletal Syndrome
  • Minneapolis, Minnesota
    University of Minnesota
Jun 28, 2023

Colorectal Cancer Trial in Tampa (Educational Intervention)

Active, not recruiting
  • Colorectal Cancer
  • Educational Intervention
  • Tampa, Florida
    Moffitt Cancer Center
Dec 30, 2022

Non-Squamous NSCLC Trial in Portugal (Erlotinib)

Completed
Has Results
  • Non-Squamous Non-Small Cell Lung Cancer
  • Aveiro, Portugal
  • +8 more
Oct 29, 2018

Breast Cancer, Breast Tumor, Breast Malignant Tumor Trial in Kaohsiung (The Breast Cancer Self-Care App)

Completed
  • Breast Cancer
  • +4 more
  • The Breast Cancer Self-Care App
  • Kaohsiung, Taiwan
    Kaohsiung Medical University
Oct 10, 2022

Ovarian Cancer Trial in Wuhan (KM1, Chemotherapy)

Not yet recruiting
  • Ovarian Cancer
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Jan 5, 2023

Solid Tumors Trial in Guangzhou, Hangzhou (Nivolumab)

Completed
  • Solid Tumors
  • Guangzhou, Guangdong, China
  • +1 more
Mar 14, 2022

Breast Cancer Trial in San Francisco (Intake Session, Individual Sessions, Group Sessions)

Not yet recruiting
  • Breast Cancer
  • Intake Session
  • +4 more
  • San Francisco, California
    Zuckerberg San Francisco General
Sep 20, 2023

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Head Neck Cancer, Oral Cancer Trial in Varanasi (Surface Electromyography and Video fluoroscopy)

Completed
  • Head Neck Cancer
  • Oral Cancer
  • Surface Electromyography and Video fluoroscopy
  • Varanasi, UP, India
    Banaras Hindu University
Apr 18, 2023

Preoperative Frailty in Elderly Colorectal Cancer and

Completed
  • Colorectal Cancer
    • Zunyi, Guizhou, China
      Yongmei Zhang
    Jun 21, 2023

    Advanced Solid Tumours Trial (RC88+JS001)

    Not yet recruiting
    • Advanced Solid Tumours
    • (no location specified)
    Mar 26, 2023

    Solid Tumor Trial in Australia (YH003, YH001, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • Blacktown, New South Wales, Australia
    • +3 more
    Apr 6, 2022

    Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

    Recruiting
    • Prostate Cancer
    • Nanjing, Jiangsu, China
      68Ga-PSMA-33 PET/CT imaging
    Sep 19, 2023

    Furmonertinib, EGFR-mutation, NSCLC Trial in Beijing (Furmonertinib)

    Recruiting
    • Furmonertinib
    • +3 more
    • Beijing, China
      Ethics Committee
    Jul 15, 2022

    Participants With Breast Cancer Metastatic in the Bone

    Recruiting
    • Bone Pain
    • Breast Carcinoma Metastatic in the Bone
    • Biospecimen Collection
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences
    Sep 13, 2022

    Lung Cancer, High-Risk Cancer, Smoking Trial in Taichung (Low dose computed tomography)

    Recruiting
    • Lung Cancer
    • +4 more
    • Low dose computed tomography
    • Taichung, Taiwan
      Chung Shan Medical University
    Dec 22, 2022

    Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1

    Completed
    Has Results
    • Neoplasms
    • +4 more
    • ETBX-051; adenoviral brachyury vaccine
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 25, 2020

    Recurrence Among Low Risk Endometrial Cancer Patients

    Recruiting
    • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
    • FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
    • Bilateral Salpingectomy with Oophorectomy
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes Trial in Boston (Polygenic risk score (PRS))

    Recruiting
    • Coronary Artery Disease
    • +5 more
    • Polygenic risk score (PRS)
    • Boston, Massachusetts
      VA Boston Healthcare System
    Sep 29, 2022

    Acute Lymphoblastic Leukemia, Pediatric Trial in Bratislava (Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518, Physical

    Recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • Lacticaseibacillus paracasei subsp. Paracasei CNCMI-1518
    • Physical exercise
    • Bratislava, Slovakia
      Department of Pediatric Hematology National Institute of Childre
    Jul 12, 2023

    MicroRNA Markers in Head and Neck Cancers

    Active, not recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Tissue collection
    • Aurora, Colorado
      University of Colorado Cancer Center
    Feb 1, 2023

    Hepatocellular Carcinoma Trial in Taichung (Xiang Sha Liu Jun Zi Decoction dry powder, XSLJZ Placebo)

    Enrolling by invitation
    • Hepatocellular Carcinoma
    • Xiang Sha Liu Jun Zi Decoction dry powder
    • XSLJZ Placebo
    • Taichung, 西屯區, Taiwan
      China Medical University hospital
    Dec 9, 2021

    Among Reproductive Age Gynecological and Breast Cancer

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +29 more
    • Healthcare Activity
    • Survey Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 2, 2022